Aprea Therapeutics Inc

NASDAQ:APRE   1:48:16 PM EDT
0.50
+0.02 (+4.73%)
Earnings Announcements

Aprea Therapeutics Reports Third Quarter 2022 Financial Results

Published: 11/09/2022 21:30 GMT
Aprea Therapeutics Inc (APRE) - Aprea Therapeutics Reports Third Quarter 2022 Financial Results and Provides Update on Business Operations.
Aprea Therapeutics Inc - Qtrly Loss per Share $0.12.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.13

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.10

More details on our Analysts Page.